"We're seeing the lives of pregnant people be put in jeopardy," Fatima Goss Graves, president and CEO of the National Women's Law Center, said Wednesday. "We're seeing women who have become infertile, who have been subject to sepsis and we're now hearing reports with death."
Even if a Trump administration abandons the guidance of the law, Goss Graves said advocacy groups like hers will continue a legal fight for the Biden administration's interpretation of the law.
Some doctors and hospitals also have said the federal guidance offered a protection for them to perform emergency abortions in states like Idaho and Texas, where threat of prosecution for performing an abortion hangs over their decision-making.
Trump has said he supports exceptions for rape and incest cases, as well as when a woman's life is at risk. But he has not gone as far as saying he supports exemptions when a woman's health is on the line.
Abortions might be necessary to prevent organ loss, significant hemorrhage or dangerous infections for pregnant women in rare but serious scenarios. In cases like ectopic pregnancy, premature rupture of membranes and placental abruptions, a fetus might still be alive but continuing the pregnancy can be detrimental. Doctors have argued that the legal gray area has put them in a bind.
In Idaho, for example, one hospital resorted to airlifting women out of the state after a strict abortion ban, which only allowed for abortions to prevent a woman's death, was enacted.
The Biden administration sued Idaho, arguing its state law conflicted with federal law requiring hospitals to provide stabilizing treatment, which might include abortions, for patients. The state amended its law to allow abortions for ectopic pregnancies, but other dangerous scenarios still remain unaccounted for. The Supreme Court declined to address the issue earlier this year, issuing a limited order that cleared the way for hospitals to provide emergency abortions while the case worked its way through lower courts.
Enforcement of the federal law, however, is on hold in Texas, which challenged the Biden administration's guidance on emergency abortions.
A patchwork of state laws governing abortion will remain in place under the Trump administration. Voters in Florida, Nebraska and South Dakota on Tuesday defeated constitutional amendments, leaving bans in place.
In Missouri, however, voters approved a ballot measure on Tuesday to undo one of the nation's strictest bans. Abortion rights amendments also passed in Arizona, Colorado, Maryland and Montana. Nevada voters also approved an amendment, but they'll need to pass it again in 2026 for it to take effect.
The ease with which women have been able to get abortion pills could also be up for reconsideration under Trump.
During the COVID-19 pandemic, the Food and Drug Administration made it easier to obtain abortion pills, including mifepristone, allowing women to access the medication over telehealth. The agency has approved the drug's safety through 10 weeks of pregnancy, saying that adverse effects happen for .32% of patients.
Anti-abortion advocates have challenged that, arguing the medications are not safe and at the very least not fit for eased access without in-person supervision by a doctor.
Although the Supreme Court preserved access to the drug earlier this year, anti-abortion advocates and conservative states have renewed their challenge in lower courts.
Some women are worried. Telehealth company Wisp saw an immediate spike in abortion pill orders between Election Day and the following day, with a 600% increase. In states like Florida and Texas, where the medication cannot be legally shipped, the company saw a nearly 1000% percent increase in orders of so-called "morning after" pills, also known as emergency contraception.
The company fills about tens of thousands of orders monthly for reproductive products including birth control pills and abortion pills, CEO Monica Cepak told the Associated Press.
Right now women typically take a two-step regimen of mifepristone and misoprostol to complete a medication abortion. Cepak said the company will keep a "close eye" on mifepristone under a Trump administration and is prepared to shift to a misoprostol-only regimen should restriction to mifepristone be implemented.
But Trump could be a wild card on the issue, said Mary Ziegler, a law professor at the University of California, Davis who is an expert on reproductive health issues. In the final months of the campaign, he backed away from a more rigid stance on abortion -- even saying he would not sign a national abortion ban if it came across his desk.
Although he has enjoyed firm backing from anti-abortion groups, he is willing to break with allies when he wants.
"I don't think we have a clear sense from him about what he would do," Ziegler said.